Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion. J of Skin [Internet]. 2020 Oct. 27 [cited 2025 May 9];4(6):s79. Available from: https://skin.dermsquared.com/skin/article/view/1112